W M Yeung1, S M McPhail2,3, S S Kuys4,5. 1. Department of Physiotherapy, Princess Alexandra Hospital, Metro South Hospital and Health Service, Ipswich Road, Brisbane, QLD, 4102, Australia. iwa.yeung@health.qld.gov.au. 2. Principal Research Fellow, School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia. 3. Centre for Functioning and Health Research, Metro South Hospital and Health Service, Brisbane, QLD, Australia. 4. Allied Health Research Collaborative, Metro North Hospital and Health Service, Brisbane, QLD, Australia. 5. School of Allied Health Sciences, Griffith Health Institute, Griffith University, Gold Coast, QLD, Australia.
Abstract
INTRODUCTION: Axillary web syndrome (AWS) can result in early post-operative and long-term difficulties following lymphadenectomy for cancer and should be recognised by clinicians. This systematic review was conducted to synthesise information on AWS clinical presentation and diagnosis, frequency, natural progression, grading, pathoaetiology, risk factors, symptoms, interventions and outcomes. METHODS: Electronic searches were conducted using Cochrane, Pubmed, MEDLINE, CINAHL, EMBASE, AMED, PEDro and Google Scholar until June 2013. The methodological quality of included studies was determined using the Downs and Black checklist. Narrative synthesis of results was undertaken. RESULTS: Thirty-seven studies with methodological quality scores ranging from 11 to 26 on a 28-point scale were included. AWS diagnosis relies on inspection and palpation; grading has not been validated. AWS frequency was reported in up to 85.4 % of patients. Biopsies identified venous and lymphatic pathoaetiology with five studies suggesting lymphatic involvement. Twenty-one studies reported AWS occurrence within eight post-operative weeks, but late occurrence of greater than 3 months is possible. Pain was commonly reported with shoulder abduction more restricted than flexion. AWS symptoms usually resolve within 3 months but may persist. Risk factors may include extensiveness of surgery, younger age, lower body mass index, ethnicity and healing complications. Low-quality studies suggest that conservative approaches including analgesics, non-steroidal anti-inflammatory drugs and/or physiotherapy may be safe and effective for early symptom reduction. CONCLUSIONS: AWS appears common. Current evidence for the treatment of AWS is insufficient to provide clear guidance for clinical practice. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors should be informed about AWS. Further investigation is needed into pathoaetiology, long-term outcomes and to determine effective treatment using standardised outcomes.
INTRODUCTION:Axillary web syndrome (AWS) can result in early post-operative and long-term difficulties following lymphadenectomy for cancer and should be recognised by clinicians. This systematic review was conducted to synthesise information on AWS clinical presentation and diagnosis, frequency, natural progression, grading, pathoaetiology, risk factors, symptoms, interventions and outcomes. METHODS: Electronic searches were conducted using Cochrane, Pubmed, MEDLINE, CINAHL, EMBASE, AMED, PEDro and Google Scholar until June 2013. The methodological quality of included studies was determined using the Downs and Black checklist. Narrative synthesis of results was undertaken. RESULTS: Thirty-seven studies with methodological quality scores ranging from 11 to 26 on a 28-point scale were included. AWS diagnosis relies on inspection and palpation; grading has not been validated. AWS frequency was reported in up to 85.4 % of patients. Biopsies identified venous and lymphatic pathoaetiology with five studies suggesting lymphatic involvement. Twenty-one studies reported AWS occurrence within eight post-operative weeks, but late occurrence of greater than 3 months is possible. Pain was commonly reported with shoulder abduction more restricted than flexion. AWS symptoms usually resolve within 3 months but may persist. Risk factors may include extensiveness of surgery, younger age, lower body mass index, ethnicity and healing complications. Low-quality studies suggest that conservative approaches including analgesics, non-steroidal anti-inflammatory drugs and/or physiotherapy may be safe and effective for early symptom reduction. CONCLUSIONS:AWS appears common. Current evidence for the treatment of AWS is insufficient to provide clear guidance for clinical practice. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors should be informed about AWS. Further investigation is needed into pathoaetiology, long-term outcomes and to determine effective treatment using standardised outcomes.
Entities:
Keywords:
Axillary lymphadenectomy; Axillary web syndrome; Breast cancer; Melanoma; Pain; Post-operative morbidity
Authors: Nicole L Stout; Lucinda A Pfalzer; Ellen Levy; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: PM R Date: 2011-10-05 Impact factor: 2.298
Authors: Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872
Authors: Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: Cancer Date: 2008-06-15 Impact factor: 6.860
Authors: Daniella M F Paiva; Vivian O Rodrigues; Marcelle G Cesca; Pamella V Palma; Isabel C G Leite Journal: BMC Womens Health Date: 2013-02-13 Impact factor: 2.809
Authors: Paul Sutcliffe; Steven Martin; Jackie Sturt; John Powell; Frances Griffiths; Ann Adams; Jeremy Dale Journal: BMC Endocr Disord Date: 2011-01-06 Impact factor: 2.763
Authors: Karol Ramírez-Parada; Diana Garay-Acevedo; Williams Mella-Abarca; Militza Petric-Guajardo; César Sánchez-Rojel; Margaret L McNeely; Ivana Leao-Ribeiro; Rodrigo Fernández-Verdejo Journal: Support Care Cancer Date: 2019-11-25 Impact factor: 3.603
Authors: Cheryl L Brunelle; Sacha A Roberts; Amy M Shui; Tessa C Gillespie; Kayla M Daniell; George E Naoum; Alphonse Taghian Journal: J Surg Oncol Date: 2020-06-04 Impact factor: 3.454
Authors: Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann Journal: Support Care Cancer Date: 2016-10-04 Impact factor: 3.603
Authors: Laurence Leysen; David Beckwée; Jo Nijs; Roselien Pas; Thomas Bilterys; Sofie Vermeir; Nele Adriaenssens Journal: Support Care Cancer Date: 2017-08-10 Impact factor: 3.603